speb/financial-data huggingface dataset:
PHI cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
PHI balance_sheet (quarterly, 2026-03-31) — Net Debt: 280928000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 1265000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Income: 8869000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 8855000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 8918000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 8869000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 8869000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 11257000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 8918000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Interest Income: -4149000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: 47000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -16000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -5463000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -5463000000.00
PHI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4149000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 212000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Net PPE: 374636000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -11367000000.00
PHI cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
PHI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 61516000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 357000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 1532000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 10601000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 6656000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 6576000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 10601000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 80000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3898000000.00
PHI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 31091000000.00
PHI income_statement (quarterly, 2026-03-31) — Normalized Income: 9856896064.67
PHI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 22751000000.00
PHI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -190000000.00
PHI income_statement (quarterly, 2026-03-31) — Operating Income: 14589000000.00
PHI income_statement (quarterly, 2026-03-31) — Operating Revenue: 56513000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 17171000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 29070000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 4876000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -41625000000.00
PHI income_statement (quarterly, 2026-03-31) — Other Gand A: 2068000000.00
PHI income_statement (quarterly, 2026-03-31) — Other Income Expense: 817000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1464000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Inventories: 277000000.00
PHI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 4217000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 47262000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 65000000.00
PHI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1041000000.00
PHI income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 7887000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Properties: 17621000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Receivables: 988000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 466000000.00
PHI income_statement (quarterly, 2026-03-31) — Other Taxes: 1031000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Payables: 69728000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 122304000000.00
PHI cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 414000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4980000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 450000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 510000000.00
PHI income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 14000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 510000000.00
PHI income_statement (quarterly, 2026-03-31) — Pretax Income: 11257000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
PHI cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
PHI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -40000000.00
PHI cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -11750000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Raw Materials: 801000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Receivables: 33247000000.00
PHI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 9440000000.00
PHI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 14280000000.00
PHI income_statement (quarterly, 2026-03-31) — Rent And Landing Fees: 326000000.00
PHI income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 326000000.00
PHI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -5613000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 42244000000.00
PHI income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5523000000.00
PHI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 24000000.00
PHI cash_flow (quarterly, 2026-03-31) — Sale Of Investment Properties: 47000000.00
PHI cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 383000000.00
PHI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1040000000.00
PHI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 9286000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Share Issued: 218755775.00
PHI cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 0.00
PHI cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: 0.00
PHI income_statement (quarterly, 2026-03-31) — Special Income Charges: -454000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 125921000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 61006000000.00
PHI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -259103935.33
PHI income_statement (quarterly, 2026-03-31) — Tax Provision: 2339000000.00
PHI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
PHI cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -817000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Assets: 639555000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 392313000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Debt: 357298000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 127168000000.00
PHI income_statement (quarterly, 2026-03-31) — Total Expenses: 41924000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 512387000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 564884000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 332541000000.00
PHI income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 3000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 8269000000.00
PHI income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1247000000.00
PHI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1247000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 2700000.00
PHI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 6505000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Working Capital: -105175000000.00
PHI income_statement (quarterly, 2026-03-31) — Write Off: 828000000.00
PHI.L income_statement (annual, 2021-07-31) — +Operating Expense: 729000.00
PHI.L income_statement (annual, 2021-07-31) — +Total Revenue: 9933578.10
PHI.L balance_sheet (annual, 2021-07-31) — Accounts Payable: 0.00
PHI.L balance_sheet (annual, 2021-07-31) — Additional Paid In Capital: 241721000.00
PHI.L income_statement (annual, 2021-07-31) — Basic Average Shares: 78661987.00
PHI.L income_statement (annual, 2021-07-31) — Basic EPS: 2.53
PHI.L cash_flow (annual, 2021-07-31) — Beginning Cash Position: 12146000.00
PHI.L balance_sheet (annual, 2021-07-31) — Capital Stock: 8843000.00
PHI.L balance_sheet (annual, 2021-07-31) — Cash And Cash Equivalents: 31766000.00
PHI.L balance_sheet (annual, 2021-07-31) — Cash Cash Equivalents And Federal Funds Sold: 31766000.00
PHI.L cash_flow (annual, 2021-07-31) — Cash Dividends Paid: -171000.00
PHI.L cash_flow (annual, 2021-07-31) — Change In Other Current Liabilities: 916000.00
PHI.L cash_flow (annual, 2021-07-31) — Change In Working Capital: 916000.00
PHI.L cash_flow (annual, 2021-07-31) — Changes In Cash: 20972000.00
PHI.L balance_sheet (annual, 2021-07-31) — Common Stock: 8843000.00
PHI.L cash_flow (annual, 2021-07-31) — Common Stock Dividend Paid: -171000.00
PHI.L balance_sheet (annual, 2021-07-31) — Common Stock Equity: 687231000.00
PHI.L cash_flow (annual, 2021-07-31) — Common Stock Issuance: 185942000.00
PHI.L cash_flow (annual, 2021-07-31) — Common Stock Payments: -2132000.00
PHI.L income_statement (annual, 2021-07-31) — Diluted Average Shares: 78661987.00
PHI.L income_statement (annual, 2021-07-31) — Diluted EPS: 2.53
PHI.L income_statement (annual, 2021-07-31) — Diluted NI Availto Com Stockholders: 199167000.00
PHI.L cash_flow (annual, 2021-07-31) — Effect Of Exchange Rate Changes: -1352000.00
PHI.L cash_flow (annual, 2021-07-31) — End Cash Position: 31766000.00
PHI.L balance_sheet (annual, 2021-07-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 725122000.00
PHI.L cash_flow (annual, 2021-07-31) — Financing Cash Flow: 221168000.00
PHI.L cash_flow (annual, 2021-07-31) — Free Cash Flow: 396000.00
PHI.L cash_flow (annual, 2021-07-31) — Gain Loss On Investment Securities: -208671000.00
PHI.L income_statement (annual, 2021-07-31) — Gain On Sale Of Security: 43403000.00
PHI.L income_statement (annual, 2021-07-31) — General And Administrative Expense: 729000.00
PHI.L income_statement (annual, 2021-07-31) — Interest Expense: 465000.00
PHI.L income_statement (annual, 2021-07-31) — Interest Income: 66000.00
PHI.L cash_flow (annual, 2021-07-31) — Interest Paid Cfo: -430000.00
PHI.L balance_sheet (annual, 2021-07-31) — Invested Capital: 748014000.00
PHI.L cash_flow (annual, 2021-07-31) — Investing Cash Flow: -200592000.00
PHI.L balance_sheet (annual, 2021-07-31) — Investmentin Financial Assets: 725122000.00
PHI.L balance_sheet (annual, 2021-07-31) — Investments And Advances: 725122000.00
PHI.L cash_flow (annual, 2021-07-31) — Issuance Of Capital Stock: 185942000.00
PHI.L cash_flow (annual, 2021-07-31) — Issuance Of Debt: 210000000.00
PHI.L balance_sheet (annual, 2021-07-31) — Long Term Debt And Capital Lease Obligation: 60783000.00
PHI.L cash_flow (annual, 2021-07-31) — Long Term Debt Issuance: 210000000.00
PHI.L cash_flow (annual, 2021-07-31) — Long Term Debt Payments: -172471000.00
PHI.L cash_flow (annual, 2021-07-31) — Net Common Stock Issuance: 183810000.00
PHI.L balance_sheet (annual, 2021-07-31) — Net Debt: 29017000.00
PHI.L cash_flow (annual, 2021-07-31) — Net Foreign Currency Exchange Gain Loss: -35000.00
PHI.L income_statement (annual, 2021-07-31) — Net Income: 9496805.26
PHI.L income_statement (annual, 2021-07-31) — Net Income Common Stockholders: 199167000.00
PHI.L income_statement (annual, 2021-07-31) — Net Income Continuous Operations: 199167000.00
PHI.L income_statement (annual, 2021-07-31) — Net Income From Continuing And Discontinued Operation: 199167000.00
PHI.L income_statement (annual, 2021-07-31) — Net Income From Continuing Operation Net Minority Interest: 199167000.00
PHI.L cash_flow (annual, 2021-07-31) — Net Income From Continuing Operations: 207598000.00
PHI.L income_statement (annual, 2021-07-31) — Net Income Including Noncontrolling Interests: 199167000.00
PHI.L income_statement (annual, 2021-07-31) — Net Interest Income: -399000.00
PHI.L cash_flow (annual, 2021-07-31) — Net Investment Purchase And Sale: -200592000.00
PHI.L cash_flow (annual, 2021-07-31) — Net Issuance Payments Of Debt: 37529000.00
PHI.L cash_flow (annual, 2021-07-31) — Net Long Term Debt Issuance: 37529000.00
PHI.L cash_flow (annual, 2021-07-31) — Net Other Financing Charges: 0.00
PHI.L balance_sheet (annual, 2021-07-31) — Net Tangible Assets: 687231000.00
PHI.L income_statement (annual, 2021-07-31) — Normalized Income: 199167000.00
PHI.L cash_flow (annual, 2021-07-31) — Operating Cash Flow: 396000.00
PHI.L income_statement (annual, 2021-07-31) — Operating Revenue: 9933578.10
PHI.L balance_sheet (annual, 2021-07-31) — Ordinary Shares Number: 88429704.00
PHI.L balance_sheet (annual, 2021-07-31) — Other Payable: 1183000.00
PHI.L balance_sheet (annual, 2021-07-31) — Payables: 1183000.00
PHI.L income_statement (annual, 2021-07-31) — Pretax Income: 207598000.00
PHI.L cash_flow (annual, 2021-07-31) — Purchase Of Investment: -298606000.00
PHI.L balance_sheet (annual, 2021-07-31) — Receivables: 1387000.00
PHI.L cash_flow (annual, 2021-07-31) — Repayment Of Debt: -172471000.00
PHI.L cash_flow (annual, 2021-07-31) — Repurchase Of Capital Stock: -2132000.00
PHI.L cash_flow (annual, 2021-07-31) — Sale Of Investment: 98014000.00
PHI.L income_statement (annual, 2021-07-31) — Selling General And Administration: 729000.00
PHI.L balance_sheet (annual, 2021-07-31) — Share Issued: 88429704.00
PHI.L balance_sheet (annual, 2021-07-31) — Stockholders Equity: 687231000.00
PHI.L balance_sheet (annual, 2021-07-31) — Tangible Book Value: 687231000.00
PHI.L income_statement (annual, 2021-07-31) — Tax Effect Of Unusual Items: 0.00
PHI.L income_statement (annual, 2021-07-31) — Tax Provision: 8431000.00
PHI.L income_statement (annual, 2021-07-31) — Tax Rate For Calcs: 0.04
PHI.L cash_flow (annual, 2021-07-31) — Taxes Refund Paid: 553000.00
PHI.L balance_sheet (annual, 2021-07-31) — Total Assets: 758275000.00
PHI.L balance_sheet (annual, 2021-07-31) — Total Capitalization: 748014000.00
PHI.L balance_sheet (annual, 2021-07-31) — Total Debt: 60783000.00
PHI.L balance_sheet (annual, 2021-07-31) — Total Equity Gross Minority Interest: 687231000.00
PHI.L balance_sheet (annual, 2021-07-31) — Total Liabilities Net Minority Interest: 71044000.00
PHI.L income_statement (annual, 2022-07-31) — +Operating Expense: 1093000.00
PHI.L income_statement (annual, 2022-07-31) — +Total Revenue: -111027000.00
PHI.L balance_sheet (annual, 2022-07-31) — Accounts Payable: 446000.00
PHI.L balance_sheet (annual, 2022-07-31) — Additional Paid In Capital: 274313000.00
PHI.L income_statement (annual, 2022-07-31) — Basic Average Shares: 91063205.00
PHI.L income_statement (annual, 2022-07-31) — Basic EPS: -1.19
PHI.L cash_flow (annual, 2022-07-31) — Beginning Cash Position: 31766000.00
PHI.L balance_sheet (annual, 2022-07-31) — Capital Stock: 9186000.00
PHI.L balance_sheet (annual, 2022-07-31) — Cash And Cash Equivalents: 5399000.00
PHI.L balance_sheet (annual, 2022-07-31) — Cash Cash Equivalents And Federal Funds Sold: 5399000.00
PHI.L cash_flow (annual, 2022-07-31) — Cash Dividends Paid: 0.00
PHI.L cash_flow (annual, 2022-07-31) — Change In Other Current Liabilities: 0.00
PHI.L cash_flow (annual, 2022-07-31) — Change In Payable: -9000.00
PHI.L cash_flow (annual, 2022-07-31) — Change In Receivables: -580000.00
PHI.L cash_flow (annual, 2022-07-31) — Change In Working Capital: -589000.00
PHI.L cash_flow (annual, 2022-07-31) — Changes In Cash: -30461000.00
PHI.L balance_sheet (annual, 2022-07-31) — Common Stock: 9186000.00
PHI.L cash_flow (annual, 2022-07-31) — Common Stock Dividend Paid: 0.00
PHI.L balance_sheet (annual, 2022-07-31) — Common Stock Equity: 610550000.00
PHI.L cash_flow (annual, 2022-07-31) — Common Stock Issuance: 32957000.00
PHI.L cash_flow (annual, 2022-07-31) — Common Stock Payments: -1454000.00
PHI.L income_statement (annual, 2022-07-31) — Diluted Average Shares: 91063205.00
PHI.L income_statement (annual, 2022-07-31) — Diluted EPS: -1.19
PHI.L income_statement (annual, 2022-07-31) — Diluted NI Availto Com Stockholders: -108184000.00
PHI.L cash_flow (annual, 2022-07-31) — Effect Of Exchange Rate Changes: 4094000.00
PHI.L cash_flow (annual, 2022-07-31) — End Cash Position: 5399000.00
PHI.L balance_sheet (annual, 2022-07-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 608539000.00
PHI.L cash_flow (annual, 2022-07-31) — Financing Cash Flow: -32082000.00
PHI.L cash_flow (annual, 2022-07-31) — Free Cash Flow: 2522000.00
PHI.L cash_flow (annual, 2022-07-31) — Gain Loss On Investment Securities: 118594000.00
PHI.L income_statement (annual, 2022-07-31) — Gain On Sale Of Security: 48991000.00
PHI.L income_statement (annual, 2022-07-31) — General And Administrative Expense: 1008000.00
PHI.L income_statement (annual, 2022-07-31) — Interest Expense: 756000.00
PHI.L income_statement (annual, 2022-07-31) — Interest Income: 7000.00
PHI.L cash_flow (annual, 2022-07-31) — Interest Paid Cfo: -765000.00
PHI.L balance_sheet (annual, 2022-07-31) — Invested Capital: 610602000.00
PHI.L cash_flow (annual, 2022-07-31) — Investing Cash Flow: -901000.00
PHI.L balance_sheet (annual, 2022-07-31) — Investmentin Financial Assets: 608539000.00
PHI.L balance_sheet (annual, 2022-07-31) — Investments And Advances: 608539000.00
PHI.L cash_flow (annual, 2022-07-31) — Issuance Of Capital Stock: 32957000.00
PHI.L cash_flow (annual, 2022-07-31) — Issuance Of Debt: 119372000.00
PHI.L balance_sheet (annual, 2022-07-31) — Long Term Debt And Capital Lease Obligation: 52000.00
PHI.L cash_flow (annual, 2022-07-31) — Long Term Debt Issuance: 119372000.00
PHI.L cash_flow (annual, 2022-07-31) — Long Term Debt Payments: -182957000.00
PHI.L cash_flow (annual, 2022-07-31) — Net Common Stock Issuance: 31503000.00
PHI.L cash_flow (annual, 2022-07-31) — Net Foreign Currency Exchange Gain Loss: -1292000.00
PHI.L income_statement (annual, 2022-07-31) — Net Income: -108184000.00
PHI.L income_statement (annual, 2022-07-31) — Net Income Common Stockholders: -108184000.00
PHI.L income_statement (annual, 2022-07-31) — Net Income Continuous Operations: -108184000.00
PHI.L income_statement (annual, 2022-07-31) — Net Income From Continuing And Discontinued Operation: -108184000.00
PHI.L income_statement (annual, 2022-07-31) — Net Income From Continuing Operation Net Minority Interest: -108184000.00
PHI.L cash_flow (annual, 2022-07-31) — Net Income From Continuing Operations: -112120000.00
PHI.L income_statement (annual, 2022-07-31) — Net Income Including Noncontrolling Interests: -108184000.00
PHI.L income_statement (annual, 2022-07-31) — Net Interest Income: -749000.00
PHI.L cash_flow (annual, 2022-07-31) — Net Investment Purchase And Sale: -901000.00
PHI.L cash_flow (annual, 2022-07-31) — Net Issuance Payments Of Debt: -63585000.00
PHI.L cash_flow (annual, 2022-07-31) — Net Long Term Debt Issuance: -63585000.00
PHI.L cash_flow (annual, 2022-07-31) — Net Other Financing Charges: 0.00
PHI.L balance_sheet (annual, 2022-07-31) — Net Tangible Assets: 610550000.00
PHI.L income_statement (annual, 2022-07-31) — Normalized Income: -108184000.00
PHI.L cash_flow (annual, 2022-07-31) — Operating Cash Flow: 2522000.00
PHI.L income_statement (annual, 2022-07-31) — Operating Revenue: -111027000.00
PHI.L balance_sheet (annual, 2022-07-31) — Ordinary Shares Number: 91860961.00
PHI.L cash_flow (annual, 2022-07-31) — Other Non Cash Items: 756000.00
PHI.L balance_sheet (annual, 2022-07-31) — Other Payable: 1122000.00
PHI.L balance_sheet (annual, 2022-07-31) — Payables: 1568000.00
PHI.L income_statement (annual, 2022-07-31) — Pretax Income: -112120000.00
PHI.L cash_flow (annual, 2022-07-31) — Purchase Of Investment: -197017000.00
PHI.L balance_sheet (annual, 2022-07-31) — Receivables: 1248000.00
PHI.L cash_flow (annual, 2022-07-31) — Repayment Of Debt: -182957000.00
PHI.L cash_flow (annual, 2022-07-31) — Repurchase Of Capital Stock: -1454000.00
PHI.L cash_flow (annual, 2022-07-31) — Sale Of Investment: 196116000.00
PHI.L income_statement (annual, 2022-07-31) — Selling And Marketing Expense: 85000.00
PHI.L income_statement (annual, 2022-07-31) — Selling General And Administration: 1093000.00
PHI.L balance_sheet (annual, 2022-07-31) — Share Issued: 92074961.00
PHI.L balance_sheet (annual, 2022-07-31) — Stockholders Equity: 610550000.00
PHI.L balance_sheet (annual, 2022-07-31) — Tangible Book Value: 610550000.00
PHI.L income_statement (annual, 2022-07-31) — Tax Effect Of Unusual Items: 0.00
PHI.L income_statement (annual, 2022-07-31) — Tax Provision: -3936000.00
PHI.L income_statement (annual, 2022-07-31) — Tax Rate For Calcs: 0.04
PHI.L cash_flow (annual, 2022-07-31) — Taxes Refund Paid: -2062000.00
PHI.L balance_sheet (annual, 2022-07-31) — Total Assets: 615186000.00
PHI.L balance_sheet (annual, 2022-07-31) — Total Capitalization: 610602000.00
PHI.L balance_sheet (annual, 2022-07-31) — Total Debt: 52000.00
PHI.L balance_sheet (annual, 2022-07-31) — Total Equity Gross Minority Interest: 610550000.00
PHI.L balance_sheet (annual, 2022-07-31) — Total Liabilities Net Minority Interest: 4636000.00
PHI.L balance_sheet (annual, 2022-07-31) — Treasury Shares Number: 214000.00
PHI.L income_statement (annual, 2023-07-31) — +Operating Expense: 762000.00
PHI.L income_statement (annual, 2023-07-31) — +Total Revenue: -20437000.00
PHI.L balance_sheet (annual, 2023-07-31) — Accounts Payable: 0.00
PHI.L balance_sheet (annual, 2023-07-31) — Additional Paid In Capital: 274487000.00
PHI.L income_statement (annual, 2023-07-31) — Basic Average Shares: 91364427.00
PHI.L income_statement (annual, 2023-07-31) — Basic EPS: -0.25
PHI.L cash_flow (annual, 2023-07-31) — Beginning Cash Position: 5399000.00
PHI.L balance_sheet (annual, 2023-07-31) — Capital Stock: 9108000.00
PHI.L balance_sheet (annual, 2023-07-31) — Cash And Cash Equivalents: 12442000.00
PHI.L balance_sheet (annual, 2023-07-31) — Cash Cash Equivalents And Federal Funds Sold: 12442000.00
PHI.L cash_flow (annual, 2023-07-31) — Cash Dividends Paid: -2745000.00
PHI.L cash_flow (annual, 2023-07-31) — Change In Other Current Liabilities: 0.00
PHI.L cash_flow (annual, 2023-07-31) — Change In Payable: -11000.00
PHI.L cash_flow (annual, 2023-07-31) — Change In Receivables: 523000.00
PHI.L cash_flow (annual, 2023-07-31) — Change In Working Capital: 512000.00
PHI.L cash_flow (annual, 2023-07-31) — Changes In Cash: 7834000.00
PHI.L balance_sheet (annual, 2023-07-31) — Common Stock: 9108000.00
PHI.L cash_flow (annual, 2023-07-31) — Common Stock Dividend Paid: -2745000.00
PHI.L balance_sheet (annual, 2023-07-31) — Common Stock Equity: 580355000.00
PHI.L cash_flow (annual, 2023-07-31) — Common Stock Issuance: 1376000.00
PHI.L cash_flow (annual, 2023-07-31) — Common Stock Payments: -5541000.00
PHI.L income_statement (annual, 2023-07-31) — Diluted Average Shares: 91364427.00
PHI.L income_statement (annual, 2023-07-31) — Diluted EPS: -0.25
PHI.L income_statement (annual, 2023-07-31) — Diluted NI Availto Com Stockholders: -23285000.00
PHI.L cash_flow (annual, 2023-07-31) — Effect Of Exchange Rate Changes: -791000.00
PHI.L cash_flow (annual, 2023-07-31) — End Cash Position: 12442000.00
PHI.L balance_sheet (annual, 2023-07-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 572748000.00
PHI.L cash_flow (annual, 2023-07-31) — Financing Cash Flow: -6910000.00
PHI.L cash_flow (annual, 2023-07-31) — Free Cash Flow: 4447000.00
PHI.L cash_flow (annual, 2023-07-31) — Gain Loss On Investment Securities: 25404000.00
PHI.L income_statement (annual, 2023-07-31) — Gain On Sale Of Security: 14553000.00
PHI.L income_statement (annual, 2023-07-31) — General And Administrative Expense: 691000.00
PHI.L income_statement (annual, 2023-07-31) — Interest Expense: 403000.00
PHI.L income_statement (annual, 2023-07-31) — Interest Income: 163000.00
PHI.L cash_flow (annual, 2023-07-31) — Interest Paid Cfo: -403000.00
PHI.L balance_sheet (annual, 2023-07-31) — Invested Capital: 580407000.00
PHI.L cash_flow (annual, 2023-07-31) — Investing Cash Flow: 10297000.00
PHI.L balance_sheet (annual, 2023-07-31) — Investmentin Financial Assets: 572748000.00
PHI.L balance_sheet (annual, 2023-07-31) — Investments And Advances: 572748000.00
PHI.L cash_flow (annual, 2023-07-31) — Issuance Of Capital Stock: 1376000.00
PHI.L cash_flow (annual, 2023-07-31) — Issuance Of Debt: 0.00
PHI.L balance_sheet (annual, 2023-07-31) — Long Term Debt And Capital Lease Obligation: 52000.00
PHI.L cash_flow (annual, 2023-07-31) — Long Term Debt Issuance: 0.00
PHI.L cash_flow (annual, 2023-07-31) — Long Term Debt Payments: 0.00
PHI.L cash_flow (annual, 2023-07-31) — Net Common Stock Issuance: -4165000.00
PHI.L cash_flow (annual, 2023-07-31) — Net Foreign Currency Exchange Gain Loss: 791000.00
PHI.L income_statement (annual, 2023-07-31) — Net Income: -23285000.00
PHI.L income_statement (annual, 2023-07-31) — Net Income Common Stockholders: -23285000.00
PHI.L income_statement (annual, 2023-07-31) — Net Income Continuous Operations: -23285000.00
PHI.L income_statement (annual, 2023-07-31) — Net Income From Continuing And Discontinued Operation: -23285000.00
PHI.L income_statement (annual, 2023-07-31) — Net Income From Continuing Operation Net Minority Interest: -23285000.00
PHI.L cash_flow (annual, 2023-07-31) — Net Income From Continuing Operations: -21199000.00
PHI.L income_statement (annual, 2023-07-31) — Net Income Including Noncontrolling Interests: -23285000.00
PHI.L income_statement (annual, 2023-07-31) — Net Interest Income: -240000.00
PHI.L cash_flow (annual, 2023-07-31) — Net Investment Purchase And Sale: 10297000.00
PHI.L cash_flow (annual, 2023-07-31) — Net Issuance Payments Of Debt: 0.00
PHI.L cash_flow (annual, 2023-07-31) — Net Long Term Debt Issuance: 0.00
PHI.L cash_flow (annual, 2023-07-31) — Net Other Financing Charges: 0.00
PHI.L balance_sheet (annual, 2023-07-31) — Net Tangible Assets: 580355000.00
PHI.L income_statement (annual, 2023-07-31) — Normalized Income: -23285000.00
PHI.L cash_flow (annual, 2023-07-31) — Operating Cash Flow: 4447000.00
PHI.L income_statement (annual, 2023-07-31) — Operating Revenue: -20437000.00
PHI.L balance_sheet (annual, 2023-07-31) — Ordinary Shares Number: 91081949.00
PHI.L cash_flow (annual, 2023-07-31) — Other Non Cash Items: 403000.00
PHI.L balance_sheet (annual, 2023-07-31) — Other Payable: 1111000.00
PHI.L balance_sheet (annual, 2023-07-31) — Payables: 1111000.00
PHI.L income_statement (annual, 2023-07-31) — Pretax Income: -21199000.00
PHI.L cash_flow (annual, 2023-07-31) — Purchase Of Investment: -89277000.00
PHI.L balance_sheet (annual, 2023-07-31) — Receivables: 420000.00
PHI.L cash_flow (annual, 2023-07-31) — Repayment Of Debt: 0.00
PHI.L cash_flow (annual, 2023-07-31) — Repurchase Of Capital Stock: -5541000.00
PHI.L cash_flow (annual, 2023-07-31) — Sale Of Investment: 99574000.00
PHI.L income_statement (annual, 2023-07-31) — Selling And Marketing Expense: 71000.00
PHI.L income_statement (annual, 2023-07-31) — Selling General And Administration: 762000.00
PHI.L balance_sheet (annual, 2023-07-31) — Share Issued: 92074961.00
PHI.L balance_sheet (annual, 2023-07-31) — Stockholders Equity: 580355000.00
PHI.L balance_sheet (annual, 2023-07-31) — Tangible Book Value: 580355000.00
PHI.L income_statement (annual, 2023-07-31) — Tax Effect Of Unusual Items: 0.00
PHI.L income_statement (annual, 2023-07-31) — Tax Provision: 2086000.00
PHI.L income_statement (annual, 2023-07-31) — Tax Rate For Calcs: 0.19
PHI.L cash_flow (annual, 2023-07-31) — Taxes Refund Paid: -1061000.00
PHI.L balance_sheet (annual, 2023-07-31) — Total Assets: 585610000.00
PHI.L balance_sheet (annual, 2023-07-31) — Total Capitalization: 580407000.00
PHI.L balance_sheet (annual, 2023-07-31) — Total Debt: 52000.00
PHI.L balance_sheet (annual, 2023-07-31) — Total Equity Gross Minority Interest: 580355000.00
PHI.L balance_sheet (annual, 2023-07-31) — Total Liabilities Net Minority Interest: 5255000.00
PHI.L balance_sheet (annual, 2023-07-31) — Treasury Shares Number: 993012.00
PHI.L income_statement (annual, 2024-07-31) — +Operating Expense: 830000.00
PHI.L income_statement (annual, 2024-07-31) — +Total Revenue: 38453000.00
PHI.L balance_sheet (annual, 2024-07-31) — Accounts Payable: 273000.00
PHI.L balance_sheet (annual, 2024-07-31) — Additional Paid In Capital: 274487000.00
PHI.L income_statement (annual, 2024-07-31) — Basic Average Shares: 90804045.00
PHI.L income_statement (annual, 2024-07-31) — Basic EPS: 0.30
PHI.L cash_flow (annual, 2024-07-31) — Beginning Cash Position: 12442000.00
PHI.L balance_sheet (annual, 2024-07-31) — Capital Stock: 9066000.00
PHI.L balance_sheet (annual, 2024-07-31) — Cash And Cash Equivalents: 4205000.00
PHI.L balance_sheet (annual, 2024-07-31) — Cash Cash Equivalents And Federal Funds Sold: 4205000.00
PHI.L cash_flow (annual, 2024-07-31) — Cash Dividends Paid: -2954000.00
PHI.L cash_flow (annual, 2024-07-31) — Change In Other Current Liabilities: 0.00
PHI.L cash_flow (annual, 2024-07-31) — Change In Payable: 71000.00
PHI.L cash_flow (annual, 2024-07-31) — Change In Receivables: -465000.00
PHI.L cash_flow (annual, 2024-07-31) — Change In Working Capital: -394000.00
PHI.L cash_flow (annual, 2024-07-31) — Changes In Cash: -8124000.00
PHI.L balance_sheet (annual, 2024-07-31) — Common Stock: 9066000.00
PHI.L cash_flow (annual, 2024-07-31) — Common Stock Dividend Paid: -2954000.00
PHI.L balance_sheet (annual, 2024-07-31) — Common Stock Equity: 601970000.00
PHI.L cash_flow (annual, 2024-07-31) — Common Stock Issuance: 0.00
PHI.L cash_flow (annual, 2024-07-31) — Common Stock Payments: -2345000.00
PHI.L income_statement (annual, 2024-07-31) — Diluted Average Shares: 90804045.00
PHI.L income_statement (annual, 2024-07-31) — Diluted EPS: 0.30
PHI.L income_statement (annual, 2024-07-31) — Diluted NI Availto Com Stockholders: 26914000.00
PHI.L cash_flow (annual, 2024-07-31) — Effect Of Exchange Rate Changes: -113000.00
PHI.L cash_flow (annual, 2024-07-31) — End Cash Position: 4205000.00
PHI.L balance_sheet (annual, 2024-07-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 606173000.00
PHI.L cash_flow (annual, 2024-07-31) — Financing Cash Flow: -5299000.00
PHI.L cash_flow (annual, 2024-07-31) — Free Cash Flow: -3157000.00
PHI.L cash_flow (annual, 2024-07-31) — Gain Loss On Investment Securities: -33438000.00
PHI.L income_statement (annual, 2024-07-31) — Gain On Sale Of Security: 18760000.00
PHI.L income_statement (annual, 2024-07-31) — General And Administrative Expense: 740000.00
PHI.L income_statement (annual, 2024-07-31) — Interest Expense: 401000.00
PHI.L income_statement (annual, 2024-07-31) — Interest Income: 160000.00
PHI.L balance_sheet (annual, 2024-07-31) — Invested Capital: 602022000.00
PHI.L cash_flow (annual, 2024-07-31) — Investing Cash Flow: 332000.00
PHI.L balance_sheet (annual, 2024-07-31) — Investmentin Financial Assets: 606173000.00
PHI.L balance_sheet (annual, 2024-07-31) — Investments And Advances: 606173000.00
PHI.L cash_flow (annual, 2024-07-31) — Issuance Of Capital Stock: 0.00
PHI.L balance_sheet (annual, 2024-07-31) — Long Term Debt And Capital Lease Obligation: 52000.00
PHI.L cash_flow (annual, 2024-07-31) — Net Common Stock Issuance: -2345000.00
PHI.L cash_flow (annual, 2024-07-31) — Net Foreign Currency Exchange Gain Loss: 113000.00
PHI.L income_statement (annual, 2024-07-31) — Net Income: 26914000.00
PHI.L income_statement (annual, 2024-07-31) — Net Income Common Stockholders: 26914000.00
PHI.L income_statement (annual, 2024-07-31) — Net Income Continuous Operations: 26914000.00
PHI.L income_statement (annual, 2024-07-31) — Net Income From Continuing And Discontinued Operation: 26914000.00
PHI.L income_statement (annual, 2024-07-31) — Net Income From Continuing Operation Net Minority Interest: 26914000.00
PHI.L cash_flow (annual, 2024-07-31) — Net Income From Continuing Operations: 37623000.00
PHI.L income_statement (annual, 2024-07-31) — Net Income Including Noncontrolling Interests: 26914000.00
PHI.L income_statement (annual, 2024-07-31) — Net Interest Income: -241000.00
PHI.L cash_flow (annual, 2024-07-31) — Net Investment Purchase And Sale: 332000.00
PHI.L cash_flow (annual, 2024-07-31) — Net Other Financing Charges: 0.00
PHI.L balance_sheet (annual, 2024-07-31) — Net Tangible Assets: 601970000.00
PHI.L income_statement (annual, 2024-07-31) — Normalized Income: 26914000.00
PHI.L cash_flow (annual, 2024-07-31) — Operating Cash Flow: -3157000.00
PHI.L income_statement (annual, 2024-07-31) — Operating Revenue: 38453000.00
PHI.L balance_sheet (annual, 2024-07-31) — Ordinary Shares Number: 90656751.00
PHI.L cash_flow (annual, 2024-07-31) — Other Non Cash Items: 401000.00
PHI.L balance_sheet (annual, 2024-07-31) — Other Payable: 1182000.00
PHI.L balance_sheet (annual, 2024-07-31) — Payables: 1455000.00
PHI.L income_statement (annual, 2024-07-31) — Pretax Income: 37623000.00
PHI.L cash_flow (annual, 2024-07-31) — Purchase Of Investment: -206776000.00
PHI.L balance_sheet (annual, 2024-07-31) — Receivables: 790000.00
PHI.L cash_flow (annual, 2024-07-31) — Repurchase Of Capital Stock: -2345000.00
PHI.L cash_flow (annual, 2024-07-31) — Sale Of Investment: 207108000.00
PHI.L income_statement (annual, 2024-07-31) — Selling And Marketing Expense: 90000.00
PHI.L income_statement (annual, 2024-07-31) — Selling General And Administration: 830000.00
PHI.L balance_sheet (annual, 2024-07-31) — Share Issued: 92074961.00
PHI.L balance_sheet (annual, 2024-07-31) — Stockholders Equity: 601970000.00
PHI.L balance_sheet (annual, 2024-07-31) — Tangible Book Value: 601970000.00
PHI.L income_statement (annual, 2024-07-31) — Tax Effect Of Unusual Items: 0.00
PHI.L income_statement (annual, 2024-07-31) — Tax Provision: 10709000.00
PHI.L income_statement (annual, 2024-07-31) — Tax Rate For Calcs: 0.28
PHI.L cash_flow (annual, 2024-07-31) — Taxes Refund Paid: -7061000.00
PHI.L balance_sheet (annual, 2024-07-31) — Total Assets: 611168000.00
PHI.L balance_sheet (annual, 2024-07-31) — Total Capitalization: 602022000.00
PHI.L balance_sheet (annual, 2024-07-31) — Total Debt: 52000.00
PHI.L balance_sheet (annual, 2024-07-31) — Total Equity Gross Minority Interest: 601970000.00
PHI.L balance_sheet (annual, 2024-07-31) — Total Liabilities Net Minority Interest: 9198000.00
PHI.L balance_sheet (annual, 2024-07-31) — Treasury Shares Number: 1418210.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 1553000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 274487000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Capital Stock: 9007000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 3759000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Federal Funds Sold: 3759000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Common Stock: 9007000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 613744000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 632620000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Invested Capital: 629069000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Investmentin Financial Assets: 632620000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Investments And Advances: 632620000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 15325000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Net Debt: 11566000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 613744000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 90065980.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Payables: 1553000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Receivables: 842000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Share Issued: 92074961.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 613744000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 613744000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Total Assets: 637221000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 629069000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Total Debt: 15325000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 613744000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 23477000.00
PHI.L balance_sheet (quarterly, 2025-01-31) — Treasury Shares Number: 2008981.00
PHI.L cash_flow (annual, 2025-07-31) — Other Non Cash Items: 1437000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 66606000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 274487000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Capital Stock: 8297000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 6892000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Federal Funds Sold: 6892000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Common Stock: 8297000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 809883000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 866591000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Investmentin Financial Assets: 866591000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Investments And Advances: 866591000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 809883000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 82962275.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Payables: 66606000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Receivables: 3006000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Share Issued: 92074961.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 809883000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 809883000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Total Assets: 876489000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 809883000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 66606000.00
PHI.L balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 9112686.00
PHI1.DE balance_sheet (annual, 2021-12-31) — Financial Assets: 2000000.00
PHI1.DE balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 47000000.00
PHI1.DE cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 1000000.00
PHI1.DE balance_sheet (annual, 2021-12-31) — Other Inventories: 1000000.00
PHI1.DE balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 2000000.00
PHI1.DE cash_flow (annual, 2021-12-31) — Sale Of Business: 107000000.00
PHI1.DE balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 544000000.00
PHI1.DE balance_sheet (annual, 2021-12-31) — Unrealized Gain Loss: -344000000.00
PHI1.DE income_statement (annual, 2022-12-31) — +Operating Expense: 7371000000.00
PHI1.DE income_statement (annual, 2022-12-31) — +Total Revenue: 17827000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 1968000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3832000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3609000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 5025000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -226000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 891000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 891000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 1357000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 77000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 338000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 952457436.00
PHI1.DE income_statement (annual, 2022-12-31) — Basic EPS: -1.68
PHI1.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2303000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -806000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -701000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1082000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 178000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1172000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1183000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -412000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Cash Equivalents: 482000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Cash Financial: 690000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 498000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1486000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -173000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Cash Flow From Discontinued Operation: -12000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Account Payable: 52000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Inventory: -572000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -84000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -199000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Payable: 52000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 52000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Receivables: -341000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: -1144000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -342000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Changes In Cash: -1172000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Common Stock: 178000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -412000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 13249000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Common Stock Issuance: 12000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: -187000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Construction In Progress: 309000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 10633000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1839000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Assets: 10259000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 230000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Debt: 95000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 325000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 1696000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 1696000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 7934000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Current Provisions: 1018000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Deferred Income Tax: -113000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Deferred Tax: -113000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Depreciation: 711000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1602000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1602000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 256000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 952457436.00
PHI1.DE income_statement (annual, 2022-12-31) — Diluted EPS: -1.68
PHI1.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -1608000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 12000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Dividends Payable: 0.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 55000000.00
PHI1.DE income_statement (annual, 2022-12-31) — EBIT: -1487000000.00
PHI1.DE income_statement (annual, 2022-12-31) — EBITDA: 115000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -2000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 112000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 41000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — End Cash Position: 1172000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Financial Assets: 4000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 322000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: 500000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Finished Goods: 1860000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: 1866000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: -979000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 4000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 2000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 21000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1488000000.00
PHI1.DE income_statement (annual, 2022-12-31) — General And Administrative Expense: 671000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Goodwill: 10238000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 13764000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 4058000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 6248000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Gross Profit: 7194000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 123000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 54000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 1357000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Income Tax Payable: 40000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Interest Expense: 244000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 244000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Interest Income: 25000000.00
PHI1.DE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 25000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -205000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Interest Payable: 71000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Interest Received Cfo: 15000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Inventory: 4049000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 19509000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1487000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 660000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Investments And Advances: 1197000000.00
PHI1.DE balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 537000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 12000000.00
PHI1.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2516000000.00